Karyopharm Therapeutics Inc. Quarterly Debt-to-equity in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Karyopharm Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q1 2015 to Q3 2024.
  • Karyopharm Therapeutics Inc. Debt-to-equity for the quarter ending September 30, 2024 was -242 %, a 61.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -242 +394 +61.9% Sep 30, 2024
Q2 2024 -273 +271 +49.8% Jun 30, 2024
Q1 2024 -312 +156 +33.2% Mar 31, 2024
Q4 2023 -421 -1.35 -0.32% Dec 31, 2023
Q3 2023 -636 -277 -77.1% Sep 30, 2023
Q2 2023 -544 -170 -45.4% Jun 30, 2023
Q1 2023 -468 -61.4 -15.1% Mar 31, 2023
Q4 2022 -420 +21.4 +4.85% Dec 31, 2022
Q3 2022 -359 +310 +46.3% Sep 30, 2022
Q2 2022 -374 -10.8K -104% Jun 30, 2022
Q1 2022 -407 -888 -184% Mar 31, 2022
Q4 2021 -441 -678 -287% Dec 31, 2021
Q3 2021 -669 -902 -388% Sep 30, 2021
Q2 2021 10.4K +10.2K +4190% Jun 30, 2021
Q1 2021 482 +234 +94.2% Mar 31, 2021
Q4 2020 236 -20.5 -7.98% Dec 31, 2020
Q3 2020 233 +72.1 +44.9% Sep 30, 2020
Q2 2020 242 +148 +156% Jun 30, 2020
Q1 2020 248 +188 +311% Mar 31, 2020
Q4 2019 257 +211 +466% Dec 31, 2019
Q3 2019 161 +129 +405% Sep 30, 2019
Q2 2019 94.7 +65.8 +228% Jun 30, 2019
Q1 2019 60.4 +33.5 +124% Mar 31, 2019
Q4 2018 45.4 +26.3 +138% Dec 31, 2018
Q3 2018 31.8 +19.2 +152% Sep 30, 2018
Q2 2018 28.9 +17.7 +158% Jun 30, 2018
Q1 2018 26.9 +15.8 +141% Mar 31, 2018
Q4 2017 19 +8.83 +86.6% Dec 31, 2017
Q3 2017 12.6 +3.12 +32.8% Sep 30, 2017
Q2 2017 11.2 +2.39 +27.2% Jun 30, 2017
Q1 2017 11.2 +3.5 +45.7% Mar 31, 2017
Q4 2016 10.2 +3.19 +45.6% Dec 31, 2016
Q3 2016 9.51 +2.95 +44.9% Sep 30, 2016
Q2 2016 8.79 +3.22 +57.8% Jun 30, 2016
Q1 2016 7.65 +2.49 +48.3% Mar 31, 2016
Q4 2015 7 Dec 31, 2015
Q3 2015 6.57 Sep 30, 2015
Q2 2015 5.57 Jun 30, 2015
Q1 2015 5.16 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.